Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Globe Registry: Globe® Pulsed Field System Registry Study for Treating Patients With Symptomatic Atrial Fibrillation

NCT: NCT07651852 · NOT_YET_RECRUITING

NCT IDNCT07651852
StatusNOT_YET_RECRUITING
Start Date2026-07
Completion2029-10
SponsorKardium Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This post-market registry is designed to collect real world data on the use of the Globe PF System for the treatment of atrial fibrillation (AF).

Frequently Asked Questions

What is Globe Registry: Globe® Pulsed Field System Registry Study for Treating Patients With Symptomatic Atrial Fibrillation?

Globe Registry: Globe® Pulsed Field System Registry Study for Treating Patients With Symptomatic Atrial Fibrillation is a clinical trial registered under NCT07651852. Current status: NOT_YET_RECRUITING.

What is the status of NCT07651852?

The current status of NCT07651852 (Globe Registry: Globe® Pulsed Field System Registry Study for Treating Patients With Symptomatic Atrial Fibrillation) is: NOT_YET_RECRUITING.

When did Globe Registry: Globe® Pulsed Field System Registry Study for Treating Patients With Symptomatic Atrial Fibrillation start?

Globe Registry: Globe® Pulsed Field System Registry Study for Treating Patients With Symptomatic Atrial Fibrillation started on 2026-07.

Related Devices

K250747Globe® Pulsed Field SystemKardium, Inc. PMA P240044Percutaneous Cardiac Ablation Catheter for Treatment of Atrial Fibrillation with Irreversible ElectroporationKardium, Inc. K250529Globe Introducer (601-01001)Kardium, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑